Phase I study of the safety, tolerability, and potential therapeutic dose of OMT-110 for patients with refractory metastatic Colorectal Cancer

Authors

Institutions

Publication Details

Journal
BMC Cancer
Published
2025-05-25
DOI
https://doi.org/10.1186/s12885-025-14351-1
Primary Topic
Colorectal Cancer Treatments and Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Phase I study of the safety, tolerability, and potential therapeutic dose of OMT-110 for patients with refractory metastatic Colorectal Cancer

Jeong‐Heum Baek, Sun Jin Sym, Haejun Lee, Youngbae Jeon et al.
BMC Cancer
Colorectal Cancer Treatments and Studies
article

Phase I study of the safety, tolerability, and potential therapeutic dose of OMT-110 for patients with refractory metastatic Colorectal Cancer

Jeong‐Heum Baek, Sun Jin Sym, Haejun Lee, Youngbae Jeon, MinJeong Jung, Bora Jeong
article en

Abstract

No abstract available for this paper.
BMC CancerVol. 25(1)
Gachon University (KR), Gachon University Gil Medical Center (KR), Gachon University Gil Hospital (KR), Korea Pharma (South Korea) (KR)
Good health and well-being
Openalex Percentile: Top 83%
Colorectal Cancer Treatments and Studies
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.